Use of Estrogens for the Prevention and Treatment of Alzheimer’s Disease
- 5 January 2000
- journal article
- review article
- Published by S. Karger AG in Dementia and Geriatric Cognitive Disorders
- Vol. 11 (1) , 1-10
- https://doi.org/10.1159/000017206
Abstract
This review examines the biological rationale for the use of estrogen replacement therapy (ERT) and the evidence for the efficacy of ERT in enhancing cognition, preventing Alzheimer’s disease (AD) and treating AD in postmenopausal women. While the biological basis for ERT as a cognition enhancer is strong and multiply mediated, the clinical evidence for its use is not as compelling and must be weighed against possible side effects. Until the results of definitive large trials are available, the use of ERT alone or in combination with other treatments is worthy of consideration.Keywords
This publication has 16 references indexed in Scilit:
- Exploring the etiology of Alzheimer disease using molecular geneticsPublished by American Medical Association (AMA) ,1997
- Estrogen replacement therapy and risk of Alzheimer diseaseArchives of internal medicine (1960), 1996
- Women Fight Uphill Battle for EquityScience, 1996
- 17-β Estradiol Protects Neurons from Oxidative Stress-Induced Cell Death in VitroBiochemical and Biophysical Research Communications, 1995
- Hydrogen peroxide mediates amyloid β protein toxicityCell, 1994
- Glucose enhancement of memory in patients with probable senile dementia of the Alzheimer's typeNeurobiology of Aging, 1993
- Estrogen replacement therapy and cognitive function in older womenPublished by American Medical Association (AMA) ,1993
- Reduced temporal lobe blood flow in alzheimer's diseaseNeurobiology of Aging, 1992
- In vivo effects by estrone sulfate on the central nervous system-senile dementia (alzheimer's type)Journal of Steroid Biochemistry, 1989
- Observations in a preliminary open trial of estradiol therapy for senile dementia-alzheimer's typePsychoneuroendocrinology, 1986